Metanx in type 2 diabetes with peripheral neuropathy: A randomized trial

American Journal of Medicine

Volumn 126, Issue 2, 2013, Pages 141-149

  Fonseca, Vivian A ^a,b   Lavery, Lawrence A ^c   Thethi, Tina K ^a,b   Daoud, Yahya ^d   Desouza, Cyrus ^e   Ovalle, Fernando ^f   Denham, Douglas S ^g   Bottiglieri, Teodoro ^h   Sheehan, Peter ⁱ   Rosenstock, Julio ^j  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Southeast Louisiana Veterans Health Care System   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^d BAYLOR HEALTH CARE SYSTEM   (United States)

^e VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g Dgd Research Inc   (United States)

^h BAYLOR RESEARCH INSTITUTE   (United States)

ⁱ Sheehan Health Management Consulting   (United States)

^j DALLAS DIABETES AND ENDOCRINE CENTER AT MEDICAL CITY   (United States)

more..

Author keywords

Diabetic peripheral neuropathy; Symptomatic treatment; Vitamin B complex

Indexed keywords

ANALGESIC AGENT; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METANX; METFORMIN; METHYLMALONIC ACID; PLACEBO; PYRIDOXINE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG INTOXICATION; DRUG SAFETY; FEMALE; FETAL MALNUTRITION; FOLIC ACID BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; INFESTATION; INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NEUROPATHY TOTAL SYMPTOM SCORE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL DISORDER; PAIN ASSESSMENT; PERCEPTIVE THRESHOLD; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF REPORT; SHORT FORM 36; SKIN DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIBRATION SENSE; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; HUMANS; MALE; MIDDLE AGED; PYRIDOXAL PHOSPHATE; TREATMENT OUTCOME; VITAMIN B 12;

EID: 84872593274     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.06.022     Document Type: Article

References (41)

1. C. Figueroa-Romero, M. Sadidi, E.L. Feldman Mechanisms of disease: the oxidative stress theory of diabetic neuropathy Rev Endocr Metab Disord 9 2008 301 314
2. M. Charles, N. Ejskjaer, D.R. Witte, K. Borch-Johnsen, T. Lauritzen, A. Sandbaek Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: The ADDITION-Denmark study Diabetes Care 34 2011 2244 2249
3. R.W. van Etten, E.J. de Koning, M.C. Verhaar, C.A. Gaillard, T.J. Rabelink Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate Diabetologia 45 2002 1004 1010
4. B.A. Yaqub, A. Siddique, R. Sulimani Effects of methylcobalamin on diabetic neuropathy Clin Neurol Neurosurg 94 1992 105 111
5. T. Watanabe, R. Kaji, N. Oka, W. Bara, J. Kimura Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy J Neurol Sci 122 1994 140 143
6. K. Okada, H. Tanaka, K. Temporin Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model Exp Neurol 222 2010 191 203
7. D.J. Wile, C. Toth Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy Diabetes Care 33 2010 156 161
8. L.R. Solomon Diabetes as a cause of clinically significant functional cobalamin deficiency Diabetes Care 34 2011 1077 1080
9. D.S. Bell Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy South Med J 103 2010 265 267
10. V.J. McCann, R.E. Davis Serum pyridoxal concentrations in patients with diabetic neuropathy Aust N Z J Med 8 1978 259 261
11. Maintenance and Support Services Organization Medical Dictionary for Regulatory Activities (MedDRA) 2012 MedDRA MSSO Chantilly, VA http://www.meddramsso.com/index.asp
12. H. Shevalye, P. Watcho, R. Stavnilchuk, E. Dyukova, S. Lupachyk, I.G. Obrosova Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats Diabetes 61 2012 2126 2133
13. A.M. Jacobs, D. Cheng Management of diabetic small-fiber neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate Rev Neurol Dis 8 2011 39 47
14. M.J. Walker Jr, L.M. Morris, D. Cheng Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate Rev Neurol Dis 7 2010 132 139
15. A. Boyd, C. Casselini, E. Vinik, A. Vinik Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate J Diabetes Sci Technol 5 2011 714 722
16. A.L. Boyd, P.M. Barlow, G.L. Pittenger, K.F. Simmons, A.I. Vinik Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus Diabetes Metab Syndr Obes 3 2010 431 437
17. V. Bril, R.A. Buchanan Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy Diabetes Care 29 2006 68 72
18. N. Hotta, Y. Akanuma, R. Kawamori Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial Diabetes Care 29 2006 1538 1544
19. D. Ziegler Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diabetes Care 32 Suppl 2 2009 S414 S419
20. D. Ziegler, M. Hanefeld, K.J. Ruhnau Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study) ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy Diabetes Care 22 1999 1296 1301
21. D. Ziegler, A. Ametov, A. Barinov Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial Diabetes Care 29 2006 2365 2370
22. D. Ziegler, P.A. Low, A.J. Boulton Effect of 4-year antioxidant treatment with α-lipoic acid in diabetic polyneuropathy: the NATHAN 1 trial Diabetes 56 2007 A2
23. A.S. Ametov, A. Barinov, P.J. Dyck The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial Diabetes Care 26 2003 770 776
24. M. Reljanovic, G. Reichel, K. Rett Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II) Alpha Lipoic Acid in Diabetic Neuropathy Free Radic Res 31 1999 171 179
25. D. Ziegler, P.A. Low, W.J. Litchy Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 Trial Diabetes Care 34 2011 2054 2060
26. E.J. Bastyr 3rd, K.L. Price, V. Bril Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy Clin Ther 27 2005 1278 1294
27. C.D. Ang, M.J. Alviar, A.L. Dans Vitamin B for treating peripheral neuropathy Cochrane Database Syst Rev 3 2008 CD004573
28. H. Woelk, S. Lehrl, R. Bitsch, W. Kopcke Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAP I Study) Alcohol Alcohol 33 1998 631 638
29. E.S. Stroes, E.E. van Faassen, M. Yo Folic acid reverts dysfunction of endothelial nitric oxide synthase Circ Res 86 2000 1129 1134
30. A.A. Mangoni, R.A. Sherwood, B. Asonganyi, C.G. Swift, S. Thomas, S.H. Jackson Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes Am J Hypertens 18 2005 220 226
31. L.M. Title, E. Ur, K. Giddens, M.J. McQueen, B.A. Nassar Folic acid improves endothelial dysfunction in type 2 diabetes - an effect independent of homocysteine-lowering Vasc Med 11 2006 101 109
32. C. Wheatley The return of the Scarlet Pimpernel: cobalamin in inflammation II - cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS J Nutr Environ Med 16 2007 181 211
33. D.L. Price, P.M. Rhett, S.R. Thorpe, J.W. Baynes Chelating activity of advanced glycation end-product inhibitors J Biol Chem 276 2001 48967 48972
34. A. Stitt, T.A. Gardiner, N.L. Alderson The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes Diabetes 51 2002 2826 2832
35. S. Nakamura, H. Li, A. Adijiang, M. Pischetsrieder, T. Niwa Pyridoxal phosphate prevents progression of diabetic nephropathy Nephrol Dial Transplant 22 2007 2165 2174
36. E.R. Levin, T.A. Hanscom, M. Fisher The influence of pyridoxine in diabetic peripheral neuropathy Diabetes Care 4 1981 606 609
37. D.S. Saperstein, G.I. Wolfe, G.S. Gronseth Challenges in the identification of cobalamin-deficiency polyneuropathy Arch Neurol 60 2003 1296 1301
38. D.G. Savage, J. Lindenbaum, S.P. Stabler, R.H. Allen Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies Am J Med 96 1994 239 246
39. E.A. Yetley, C.M. Pfeiffer, K.W. Phinney Biomarkers of vitamin B-12 status in NHANES: a roundtable summary Am J Clin Nutr 94 2011 313S 321S
40. G. Topal, A. Brunet, E. Millanvoye Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin Free Radic Biol Med 36 2004 1532 1541
41. R. Clarke, J. Halsey, S. Lewington Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals Arch Intern Med 170 2010 1622 1631